Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 18 and 70 years old who have been diagnosed with a specific type of advanced ovarian cancer (high-grade serous epithelial ovarian cancer, stage IIIB-C or IV), confirmed by a tissue biopsy
- The cancer must be contained within the abdominal area, with no spread to areas outside the abdomen
- Good overall health and ability to carry out daily activities (confirm with trial site for specific score requirements)
- Liver function blood test results within an acceptable range
- Kidney function blood test results within an acceptable range
- Blood cell counts (white blood cells, red blood cells, and platelets) within an acceptable range
- No serious heart, lung, liver, kidney, or nerve conditions that would make major surgery unsafe
- A negative pregnancy test (both blood and urine) at the start of the trial, for women who could become pregnant
- Having already received 3 or 4 cycles of chemotherapy before surgery (called neoadjuvant chemotherapy)
- Having had surgery that successfully removed all visible signs of cancer, without any bowel reconnection procedures
- Having signed a written agreement to take part in the trial
Who may not be able to join:
- Women whose cancer got worse or spread during their pre-surgery chemotherapy
- Women whose cancer has spread outside the abdominal area, including to lymph nodes outside the abdomen
- Women where scans or surgery showed it was not possible to remove all visible cancer
- Women who needed any bowel reconnection surgery during their tumour removal operation
- Women with an active infection of any kind
- Women who have previously had an organ or bone marrow transplant, or high-dose chemotherapy involving stem cell rescue
- Women who have taken part in another clinical trial involving an experimental drug within the last 30 days
- Women who are pregnant, breastfeeding, or planning to become pregnant or breastfeed during the study or within 30 days of finishing treatment
- Women with a history of allergic reactions to drugs similar to cisplatin or paclitaxel (chemotherapy drugs used in this trial)
- Women who have not signed the written agreement to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pedro Cascales Campos, MD, HCUVA
Phone: 968369500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free interval
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.